Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure

ClinicalTrials.gov ID: NCT05165290

Public ClinicalTrials.gov record NCT05165290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05165290
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
TearClear Corp
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Latanoprost ophthalmic solution, 0.005% Drug
  • TC-002 latanoprost ophthalmic solution, 0.005% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2021
Primary completion
Aug 31, 2022
Completion
Aug 31, 2022
Last update posted
May 24, 2022

2021 – 2022

United States locations

U.S. sites
20
U.S. states
8
U.S. cities
19
Facility City State ZIP Site status
Orange County Ophthalmology Medical Group Garden Grove California 92843
Global Research Management Glendale California 91204
North Valley Eye Medical Group Mission Hills California 91345
Eye Research Foundation Newport Beach California 92663
North Bay Eye Associates Petaluma California 94954
Martel Eye Medical Group Rancho Cordova California 95670
Wolstan & Goldberg Eye Associates Torrance California 90505
Michael K. Tran, MD Westminster California 92683
Segal Drug Trials Delray Beach Florida 33484
Shettle Eye Research Inc. Largo Florida 33773
International Research Center Tampa Florida 33603
The Eyecare Institute/Butcherton Clinical Trials Louisville Kentucky 40206
Rochester Ophthalmological Group PA Rochester New York 14618
Abrams Eye Center Cleveland Ohio 44115
Scott & Christie Associates PC Cranberry Township Pennsylvania 16066
Total Eye Care P.A. Memphis Tennessee 38119
Louis M. Alpern, M.D., M.P.H., P.A. El Paso Texas 79902
Houston Eye Associates Houston Texas 77008
R&R Research LLC San Antonio Texas 78229
San Antonio Eye Center San Antonio Texas 78238

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05165290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05165290 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →